Next Article in Journal
Hypericins as Potential Leads for New Therapeutics
Next Article in Special Issue
3-Nitropropionic Acid as a Tool to Study the Mechanisms Involved in Huntington’s Disease: Past, Present and Future
Previous Article in Journal
The Measurement of Polymer Swelling Processes by an Interferometric Method and Evaluation of Diffusion Coefficients
Previous Article in Special Issue
Melatonin and Structurally-Related Compounds Protect Synaptosomal Membranes from Free Radical Damage
Review

Novel Neuroprotective Strategies in Ischemic Retinal Lesions

1
Department of Experimental Zoology and Neurobiology, University of Pecs, H-7624 Pecs, Hungary
2
Department of Biochemistry and Medical Chemistry, University of Pecs, H-7624 Pecs, Hungary
3
Department of Anatomy, University of Pecs, H-7624 Pecs, Hungary
4
Department of Sportbiology, University of Pecs, H-7624 Pecs, Hungary
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2010, 11(2), 544-561; https://doi.org/10.3390/ijms11020544
Received: 7 January 2010 / Revised: 27 January 2010 / Accepted: 27 January 2010 / Published: 3 February 2010
(This article belongs to the Special Issue Neuroprotective Strategies (special issue))
Retinal ischemia can be effectively modeled by permanent bilateral common carotid artery occlusion, which leads to chronic hypoperfusion-induced degeneration in the entire rat retina. The complex pathways leading to retinal cell death offer a complex approach of neuroprotective strategies. In the present review we summarize recent findings with different neuroprotective candidate molecules. We describe the protective effects of intravitreal treatment with: (i) urocortin 2; (ii) a mitochondrial ATP-sensitive K+ channel opener, diazoxide; (iii) a neurotrophic factor, pituitary adenylate cyclase activating polypeptide; and (iv) a novel poly(ADP-ribose) polymerase inhibitor (HO3089). The retinoprotective effects are demonstrated with morphological description and effects on apoptotic pathways using molecular biological techniques. View Full-Text
Keywords: BCCAO; ischemia; retinoprotection; urocortin 2; diazoxide; PACAP; PARP-inhibitor; rat retina BCCAO; ischemia; retinoprotection; urocortin 2; diazoxide; PACAP; PARP-inhibitor; rat retina
Show Figures

Graphical abstract

MDPI and ACS Style

Szabadfi, K.; Mester, L.; Reglodi, D.; Kiss, P.; Babai, N.; Racz, B.; Kovacs, K.; Szabo, A.; Tamas, A.; Gabriel, R.; Atlasz, T. Novel Neuroprotective Strategies in Ischemic Retinal Lesions. Int. J. Mol. Sci. 2010, 11, 544-561. https://doi.org/10.3390/ijms11020544

AMA Style

Szabadfi K, Mester L, Reglodi D, Kiss P, Babai N, Racz B, Kovacs K, Szabo A, Tamas A, Gabriel R, Atlasz T. Novel Neuroprotective Strategies in Ischemic Retinal Lesions. International Journal of Molecular Sciences. 2010; 11(2):544-561. https://doi.org/10.3390/ijms11020544

Chicago/Turabian Style

Szabadfi, Krisztina, Laszlo Mester, Dora Reglodi, Peter Kiss, Norbert Babai, Boglarka Racz, Krisztina Kovacs, Aliz Szabo, Andrea Tamas, Robert Gabriel, and Tamas Atlasz. 2010. "Novel Neuroprotective Strategies in Ischemic Retinal Lesions" International Journal of Molecular Sciences 11, no. 2: 544-561. https://doi.org/10.3390/ijms11020544

Find Other Styles

Article Access Map by Country/Region

1
Only visits after 24 November 2015 are recorded.
Back to TopTop